Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA LUPIN AJANTA PHARMA/
LUPIN
 
P/E (TTM) x 38.3 40.7 94.0% View Chart
P/BV x 8.3 6.0 139.0% View Chart
Dividend Yield % 0.3 0.2 126.5%  

Financials

 AJANTA PHARMA   LUPIN
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-23
LUPIN
Mar-23
AJANTA PHARMA/
LUPIN
5-Yr Chart
Click to enlarge
High Rs1,426799 178.5%   
Low Rs1,062583 182.2%   
Sales per share (Unadj.) Rs297.2365.8 81.3%  
Earnings per share (Unadj.) Rs46.79.8 474.6%  
Cash flow per share (Unadj.) Rs57.129.2 195.5%  
Dividends per share (Unadj.) Rs7.004.00 175.0%  
Avg Dividend yield %0.60.6 97.2%  
Book value per share (Unadj.) Rs269.1270.7 99.4%  
Shares outstanding (eoy) m125.91454.98 27.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.21.9 221.5%   
Avg P/E ratio x26.670.2 37.9%  
P/CF ratio (eoy) x21.823.7 92.1%  
Price / Book Value ratio x4.62.6 181.1%  
Dividend payout %15.040.7 36.9%   
Avg Mkt Cap Rs m156,638314,381 49.8%   
No. of employees `000NANA-   
Total wages/salary Rs m7,85130,872 25.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m37,426166,417 22.5%  
Other income Rs m9861,509 65.4%   
Total revenues Rs m38,413167,926 22.9%   
Gross profit Rs m7,83317,206 45.5%  
Depreciation Rs m1,3088,807 14.9%   
Interest Rs m582,743 2.1%   
Profit before tax Rs m7,4537,165 104.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5732,688 58.5%   
Profit after tax Rs m5,8804,477 131.3%  
Gross profit margin %20.910.3 202.4%  
Effective tax rate %21.137.5 56.3%   
Net profit margin %15.72.7 584.0%  
BALANCE SHEET DATA
Current assets Rs m28,252124,513 22.7%   
Current liabilities Rs m11,39392,654 12.3%   
Net working cap to sales %45.019.1 235.3%  
Current ratio x2.51.3 184.5%  
Inventory Days Days6626 251.1%  
Debtors Days Days1098 10.5%  
Net fixed assets Rs m18,707103,490 18.1%   
Share capital Rs m253910 27.8%   
"Free" reserves Rs m33,624122,246 27.5%   
Net worth Rs m33,877123,156 27.5%   
Long term debt Rs m13275 4.5%   
Total assets Rs m47,047228,003 20.6%  
Interest coverage x128.63.6 3,560.6%   
Debt to equity ratio x00 16.5%  
Sales to assets ratio x0.80.7 109.0%   
Return on assets %12.63.2 398.6%  
Return on equity %17.43.6 477.5%  
Return on capital %22.28.0 276.1%  
Exports to sales %59.90-   
Imports to sales %11.50-   
Exports (fob) Rs m22,420NA-   
Imports (cif) Rs m4,293NA-   
Fx inflow Rs m22,42048,057 46.7%   
Fx outflow Rs m4,29321,752 19.7%   
Net fx Rs m18,12726,306 68.9%   
CASH FLOW
From Operations Rs m7,91818,972 41.7%  
From Investments Rs m-5,596-12,868 43.5%  
From Financial Activity Rs m-1,079-3,373 32.0%  
Net Cashflow Rs m1,2432,732 45.5%  

Share Holding

Indian Promoters % 66.2 46.8 141.6%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 25.8 45.8 56.2%  
FIIs % 9.1 16.1 56.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 33.8 53.0 63.8%  
Shareholders   54,351 281,542 19.3%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on AJANTA PHARMA vs Lupin

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs Lupin Share Price Performance

Period AJANTA PHARMA Lupin S&P BSE HEALTHCARE
1-Day 2.51% 1.23% 1.18%
1-Month 7.60% 0.15% -0.75%
1-Year 92.91% 151.14% 61.82%
3-Year CAGR 21.63% 17.13% 18.16%
5-Year CAGR 26.85% 17.42% 19.79%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the Lupin share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 66.2% stake in the company. In case of Lupin the stake stands at 47.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of Lupin.

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 7.0 per share. This amounted to a Dividend Payout ratio of 15.0%.

Lupin paid Rs 4.0, and its dividend payout ratio stood at 40.7%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of Lupin.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.